| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |